Your browser doesn't support javascript.
loading
Relative and Absolute Risk Reductions in Cardiovascular and Kidney Outcomes With Canagliflozin Across KDIGO Risk Categories: Findings From the CANVAS Program.
Neuen, Brendon L; Ohkuma, Toshiaki; Neal, Bruce; Matthews, David R; de Zeeuw, Dick; Mahaffey, Kenneth W; Fulcher, Greg; Blais, Jaime; Li, Qiang; Jardine, Meg J; Perkovic, Vlado; Wheeler, David C.
Afiliação
  • Neuen BL; The George Institute for Global Health, UNSW Sydney, Sydney, Australia.
  • Ohkuma T; The George Institute for Global Health, UNSW Sydney, Sydney, Australia.
  • Neal B; The George Institute for Global Health, UNSW Sydney, Sydney, Australia.
  • Matthews DR; Oxford Centre for Diabetes, Endocrinology and Metabolism and Harris Manchester College, University of Oxford, Oxford, United Kingdom.
  • de Zeeuw D; Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
  • Mahaffey KW; Royal North Shore Hospital, Sydney, Australia.
  • Fulcher G; Stanford Center for Clinical Research, Department of Medicine, Stanford University School of Medicine, Stanford, CA.
  • Blais J; Janssen Scientific Affairs, LLC, Titusville, NJ.
  • Li Q; The George Institute for Global Health, UNSW Sydney, Sydney, Australia.
  • Jardine MJ; The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Concord Repatriation General Hospital, Sydney, Australia.
  • Perkovic V; The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Janssen Scientific Affairs, LLC, Titusville, NJ.
  • Wheeler DC; The George Institute for Global Health, UNSW Sydney, Sydney, Australia; Centre for Nephrology, University College London, London, United Kingdom. Electronic address: d.wheeler@ucl.ac.uk.
Am J Kidney Dis ; 77(1): 23-34.e1, 2021 01.
Article em En | MEDLINE | ID: mdl-32971190
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Risco Ajustado / Diabetes Mellitus Tipo 2 / Albuminúria / Insuficiência Renal Crônica / Canagliflozina Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Risco Ajustado / Diabetes Mellitus Tipo 2 / Albuminúria / Insuficiência Renal Crônica / Canagliflozina Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article